Standardize tumor classification and variant annotation for reproducible cohort building with COSMIC
Accurate interpretation of cancer genomics depends on standardized disease classification, tumor characterization, and ...
Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma Next-generation sequencing ...
Genetic studies now identify millions of variants across human populations, yet most disease-associated signals fall outside protein-coding regions. This ...
A multi-institutional team of researchers led by teams at Children's Hospital Los Angeles and Children's Hospital of Philadelphia (CHOP) has developed a user-friendly, web-based genomic dataset ...
The World Health Organization announced Tuesday it would step up its classification of the new COVID-19 variant JN.1 to a standalone "variant of interest," after tracking the strain's rapid ascent ...
SAN FRANCISCO, March 12, 2024 /PRNewswire/ -- Invitae (OTC: NVTA), a leading medical genetics company, today announced the launch of an update to Invitae Generation™ with Clinical Variant Modeling, a ...
Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2–/ERBB2-Altered Advanced Biliary Tract Cancers Despite this apparent fracture in our field, these two lymphoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results